Holen Sie sich die Stockscreener-App
2.55
0.00%
0.00
Handel nachbörslich:
2.50
-0.05
-1.96%
Schlusskurs vom Vortag:
$2.55
Offen:
$2.67
24-Stunden-Volumen:
43,329
Relative Volume:
0.91
Marktkapitalisierung:
$5.84M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-0.9273
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
+2.00%
1M Leistung:
+22.60%
6M Leistung:
-29.24%
1J Leistung:
-38.55%
1-Tages-Spanne:
$2.55
$2.69
1-Wochen-Bereich:
$2.41
$2.79
52-Wochen-Spanne:
$1.90
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.55 | 5.84M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - caller.com
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - chieftain.com
Earnings Risk: Is Xenetic Biosciences Inc stock a value trapWeekly Trade Summary & Short-Term High Return Strategies - baoquankhu1.vn
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - hattiesburgamerican.com
Merger Talk: Can Xenetic Biosciences Inc maintain sales growthInsider Selling & Weekly Setup with High ROI Potential - baoquankhu1.vn
Aug Opening: Whats next for PGEN stockTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
FOMO Trade: Does Xenetic Biosciences Inc stock reflect fundamentals2025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Take Profit: Will Xenetic Biosciences Inc stock benefit from M A2025 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Activity Recap: Is Xenetic Biosciences Inc stock good for income investorsJuly 2025 Highlights & Daily Price Action Insights - baoquankhu1.vn
Recap Report: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Quarterly Recap: Whats the outlook for Xenetic Biosciences Incs sectorSell Signal & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Analyst Downgrade: Whats the outlook for Xenetic Biosciences Incs sectorTrade Entry Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Is Xenetic Biosciences Inc. on track to beat earningsEarnings Growth Summary & Real-Time Volume Triggers - bollywoodhelpline.com
Published on: 2026-01-14 16:49:08 - baoquankhu1.vn
Can Xenetic Biosciences Inc. stock sustain institutional interestJuly 2025 Levels & Fast Gain Swing Alerts - Улправда
Xenetic Biosciences faces ongoing delays in annual meeting - TipRanks
Xenetic Biosciences Adjourns Annual Meeting Again - TradingView — Track All Markets
Is Xenetic Biosciences Inc. (3XB0) stock safe for risk averse investorsQuarterly Trade Summary & Expert Approved Momentum Ideas - Улправда
Why Xenetic Biosciences Inc. stock is in analyst buy zoneJuly 2025 Rallies & Stock Portfolio Risk Management - ulpravda.ru
Will Xenetic Biosciences Inc. stock attract more institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - Улправда
Is Xenetic Biosciences Inc. stock a safe haven assetJuly 2025 Opening Moves & Risk Managed Investment Strategies - Улправда
XBIO: No quorum was reached, so the meeting was adjourned and will be rescheduled - TradingView — Track All Markets
Trend Recap: Is Xenetic Biosciences Inc 3XB0 stock safe for risk averse investorsQuarterly Portfolio Summary & Weekly High Momentum Picks - Bộ Nội Vụ
Xenetic Biosciences, Inc.Common Stock (NQ: XBIO - FinancialContent
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Drop in Short Interest - Defense World
Is Xenetic Biosciences Inc. stock affected by interest rate hikesCash Flow Trends & Invest With Confidence - bollywoodhelpline.com
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Xenetic Biosciences, Inc. Share Price TodayLive NASDAQ: XBIO Stock Price Charts, History - Upstox
Financial Review: Xenetic Biosciences (NASDAQ:XBIO) & Talphera (NASDAQ:TLPH) - Defense World
Aug Gainers: Will Xenetic Biosciences Inc stock attract more institutional investorsTrend Reversal & High Accuracy Investment Entry Signals - moha.gov.vn
Why Xenetic Biosciences Inc. (3XB0) stock stays on buy listsProduct Launch & High Accuracy Investment Signals - Улправда
Is Xenetic Biosciences Inc. (3XB0) stock dividend growth reliableQuarterly Earnings Summary & Community Verified Swing Trade Signals - Улправда
Will Xenetic Biosciences Inc. stock outperform growth indexesPortfolio Return Report & Reliable Entry Point Alerts - DonanımHaber
Is Xenetic Biosciences Stock Built to Withstand More Downside? - Trefis
Published on: 2025-12-19 04:46:10 - Улправда
Is Xenetic Biosciences Inc. stock gaining market sharePortfolio Risk Report & Low Risk Entry Point Tips - Улправда
Published on: 2025-12-18 17:05:35 - Улправда
Contrasting Cosmos Health (NASDAQ:COSM) and Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences Earnings Notes - Trefis
Value Recap: Will Xenetic Biosciences Inc stock attract more institutional investorsMarket Performance Report & Verified Technical Signals - moha.gov.vn
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):